(*2*)
(*5*) 
RapidEye
- Insulet (NASDAQ:PODD) mentioned it has obtained FDA clearance for its Omnipod 5 Automated Insulin Delivery, or AID, system for the remedy of type 2 diabetes in adults.
- The firm mentioned the clearance makes Omnipod 5 the one AID system authorised for each type 1 and type 2 diabetes administration.